DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.

Clin Cancer Res · 2022 · PMC9365344 · PMID 35135840

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Gene sets involved in NOTCH signaling, DNA repair, and G 2 –M checkpoint showed a trend to upregulation in ALDH1 + cells compared with ALDH1 − (Supplementary Fig.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.